CAR-T cell therapy provides long, treatment-free remissions for relapsed multiple myeloma, using genetically modified T cells ...

Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Breast cancer survivors with dense breast tissue should be proactive in their screening approach, considering both 3D ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

George: The phase 1/2 study is evaluating a new compound called DCC-3009. It is a drug that was designed specifically to work ...

The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.

Living with an incurable cancer that resists durable remission means holding hope and grief at the same time — existing between promising data and lived experience.

Life changes post-diagnosis included early retirement due to immune compromise and personal milestones like adopting a new ...

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...